| 000 | 01087 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517225005.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1942-5546 | ||
| 024 | 7 |
_a10.1016/j.mayocp.2018.03.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSilber, Michael H | |
| 245 | 0 | 0 |
_aIn Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome. _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _c07 2018 |
||
| 300 |
_a955-956 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnalgesics, Opioid |
| 650 | 0 | 4 | _aDopamine Agonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRestless Legs Syndrome |
| 700 | 1 | _aBecker, Philip M | |
| 700 | 1 | _aBuchfuhrer, Mark J | |
| 700 | 1 | _aEarley, Christopher J | |
| 700 | 1 | _aOndo, William G | |
| 700 | 1 | _aWalters, Arthur S | |
| 700 | 1 | _aWinkelman, John W | |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 93 _gno. 7 _gp. 955-956 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mayocp.2018.03.021 _zAvailable from publisher's website |
| 999 |
_c28602580 _d28602580 |
||